Artificial intelligence-enabled electrocardiography from scientific research to clinical application
Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in ...
Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...
New subgroup analysis from the Phase 3 monarchE trial that explores outcomes by nodal status for Verzenio plus endocrine therapy in HR+, HER2– high-risk early breast cancer INDIANAPOLIS, Nov. 24, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback